Injections of genetically engineered muscle tissue hold great promise in treating type 2 diabetes (T2D), according to research to be presented at the annual meeting of the European Association for the Study of Diabetes in Stockholm, Sweden (19–23 Sept).
from Medical Xpress - latest medical and health news stories https://ift.tt/6MvqNnR
